Pre-clinical

Phase I

POC Phase 2

 

 

Immune Priming
Platform

INKmune
MRD ovarian cancer

Oncology

INKmune
high risk MDS

INBXX
oncology not disclosed#1

INB16
oncology not disclosed#2

DN-TNF Platform

INB03
MDSC/CPI

INB03
trastuzumab resistance

INB03
oncology not disclosed

XPro1595
Alzheimer’s Disease

Neuro

XPro1595
neuro orphan#1

XPro1595
neuro orphan#2

XPro1595
neuro not disclosed

NeuLiv
NASH

GI

flech Clinic ready upon funding     flech3 Pre-clinical

Have a Question?
858 964 3720
Email Us
dmoss@inmunebio.com
Opening Hours
M - F 8am to 5pm PST